Javascript must be enabled to continue!
Transaminases and gamma glutamyl transpeptidase for detecting nonalcoholic steatohepatitis and fibrosis in nonalcoholic fatty liver disease
View through CrossRef
Background: Nonalcoholic steatohepatitis (NASH) and advanced fibrosis are the spectrum of nonalcoholic fatty liver disease (NAFLD) that may progress to cirrhosis.Objective: We aimed to determine the detecting capacity of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma glutamyl transpeptidase (GGT) for NASH and significant fibrosis.Methods: Demographic and laboratory data of 502 sonologically diagnosed NAFLD patients were retrospectively analysed. Area under receiver operating characteristics curve (AUROC) was performed for NASH and fibrosis score ?2 (significant fibrosis) with ALT, AST and GGT of 233 biopsied patients.Results: Of 502 patients ALT, AST and GGT was elevated in 252 (50.1 %), 184 (36.7%) and 138 (27.4%) respectively. There was no difference in histological activity and fibrosis score between normal and elevated ALT and AST. Forty two (40.2%) NASH and 23(20.2%) significant fibrosis had normal ALT level. GGT was differed in NASH and Non NASH (p< .005) and between significant fibrosis (p< .01) and insignificant fbrosis. To detect NASH AUROC curve ofGGT was 67.5%, whereas of ALT and AST was 55.2% and 55.7%. For significant fibrosis AUROC curve of ALT, AST and GGT was 44, 50 and 68.4 % respectively. GGT level of39.5 U/L could detect NASH with a 63% sensitivity and 65% specificity irrespective of sex. GGT 40.5U/L had 60% sensitivity and 59 % specificity to detect significant fibrosis. For fibrosis ?2 AUROC curve was 75.4% in male.Conclusion: No optimal ALT and AST level could detect NASH and fibrosis. GGT level of 40 U/L had a better detecting capacity for NASH and fibrosis especially in male.
Title: Transaminases and gamma glutamyl transpeptidase for detecting nonalcoholic steatohepatitis and fibrosis in nonalcoholic fatty liver disease
Description:
Background: Nonalcoholic steatohepatitis (NASH) and advanced fibrosis are the spectrum of nonalcoholic fatty liver disease (NAFLD) that may progress to cirrhosis.
Objective: We aimed to determine the detecting capacity of alanine aminotransferase (ALT), aspartate aminotransferase (AST) and gamma glutamyl transpeptidase (GGT) for NASH and significant fibrosis.
Methods: Demographic and laboratory data of 502 sonologically diagnosed NAFLD patients were retrospectively analysed.
Area under receiver operating characteristics curve (AUROC) was performed for NASH and fibrosis score ?2 (significant fibrosis) with ALT, AST and GGT of 233 biopsied patients.
Results: Of 502 patients ALT, AST and GGT was elevated in 252 (50.
1 %), 184 (36.
7%) and 138 (27.
4%) respectively.
There was no difference in histological activity and fibrosis score between normal and elevated ALT and AST.
Forty two (40.
2%) NASH and 23(20.
2%) significant fibrosis had normal ALT level.
GGT was differed in NASH and Non NASH (p< .
005) and between significant fibrosis (p< .
01) and insignificant fbrosis.
To detect NASH AUROC curve ofGGT was 67.
5%, whereas of ALT and AST was 55.
2% and 55.
7%.
For significant fibrosis AUROC curve of ALT, AST and GGT was 44, 50 and 68.
4 % respectively.
GGT level of39.
5 U/L could detect NASH with a 63% sensitivity and 65% specificity irrespective of sex.
GGT 40.
5U/L had 60% sensitivity and 59 % specificity to detect significant fibrosis.
For fibrosis ?2 AUROC curve was 75.
4% in male.
Conclusion: No optimal ALT and AST level could detect NASH and fibrosis.
GGT level of 40 U/L had a better detecting capacity for NASH and fibrosis especially in male.
.
Related Results
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED] Bridport Health Reviews - Powerfully Detoxifies The Liver, Lose Liver Fat And Improve Gut Health! v1
[RETRACTED]Product Name - Bridport Health Ingredients - Milk Thistle, Beetroot, Artichoke Extract & More. Category - Liver Support Supplement Main Benefits - Helps Protect The ...
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED] Bridport Health Liver Support Does It Really Work v1
[RETRACTED]Depiction • Where to Get Bottle Online –Click Here • Item Name -Bridport Health Liver • Aftereffects - No Major Side Effects • Classification - Health • Accessibility -O...
Clinical efficacy of S-adenosyl-L-methionine and antihypertensive combination treatment in patients with comorbid course of metabolic-associated steatotic liver disease and arterial hypertension
Clinical efficacy of S-adenosyl-L-methionine and antihypertensive combination treatment in patients with comorbid course of metabolic-associated steatotic liver disease and arterial hypertension
Objective — to determine the likely effect of S‑adenosyl‑L‑methionine (SAMe) and antihypertensive combination treatment on the clinical course, liver enzymatic activity (the levels...
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
North Syrian Mortaria and Other Late Roman Personal and Utility Objects Bearing Inscriptions of Good Luck
<span style="font-size: 11pt; color: black; font-family: 'Times New Roman','serif'">ΠΗΛΙΝΑ ΙΓ&Delta...
Tumor necrosis factor‐α‐mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice
Tumor necrosis factor‐α‐mediated hepatocyte apoptosis stimulates fibrosis in the steatotic liver in mice
Hepatocyte apoptosis has been implicated in the progression of nonalcoholic steatohepatitis. However, it is unclear whether the induction of tumor necrosis factor (TNF)‐α‐mediated ...
Modern Principles of Liver Fibrosis Diagnosis in Patients With Chronic Diffuse Liver Lesions: Literature Review and Clinical Case Description
Modern Principles of Liver Fibrosis Diagnosis in Patients With Chronic Diffuse Liver Lesions: Literature Review and Clinical Case Description
Introduction. Chronic diffuse liver lesions, which is at a certain stage and phase of the disease characterized by excessive accumulation of components of the extracellular matrix,...
The Differential Gene Expression Analysis Of Hepatic Inflammatory Genes For Diagnosis Of Early Stages Of Fibrosis In Non Alcoholic Fatty Liver Disease (NAFLD)
The Differential Gene Expression Analysis Of Hepatic Inflammatory Genes For Diagnosis Of Early Stages Of Fibrosis In Non Alcoholic Fatty Liver Disease (NAFLD)
Nonalcoholic Fatty Liver Disease (NAFLD) is the common liver metabolic disorders, which affects more than 30% of the world’s population. If NAFLD is left untreated, it progresses t...
RADIOLOGICAL SPECTRUM OF FATTY LIVER CORRELATES WITH HIGH-RESOLUTION ULTRASONOGRAPHY OF FIBROSIS AND CIRRHOSIS
RADIOLOGICAL SPECTRUM OF FATTY LIVER CORRELATES WITH HIGH-RESOLUTION ULTRASONOGRAPHY OF FIBROSIS AND CIRRHOSIS
Background: Fatty liver disease, fibrosis, and cirrhosis represent a spectrum of liver conditions that pose significant health risks globally. Accurate diagnosis and staging of the...

